These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 37131951)

  • 1. Incorporating axillary-lateral thoracic vessel juncture dosimetric variables improves model for predicting lymphedema in patients with breast cancer: A validation analysis.
    Suk Chang J; Ko H; Hee Im S; Sung Kim J; Kyung Byun H; Bae Kim Y; Jung W; Park G; Sun Lee H; Sung W; Olson R; Hong CS; Kim K
    Clin Transl Radiat Oncol; 2023 Jul; 41():100629. PubMed ID: 37131951
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Determining the Organ at Risk for Lymphedema After Regional Nodal Irradiation in Breast Cancer.
    Gross JP; Lynch CM; Flores AM; Jordan SW; Helenowski IB; Gopalakrishnan M; Cutright D; Donnelly ED; Strauss JB
    Int J Radiat Oncol Biol Phys; 2019 Nov; 105(3):649-658. PubMed ID: 31260718
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Axillary Lateral Vessel Thoracic Junction Is Not an Organ at Risk for Breast Cancer-Related Lymphedema.
    Healy E; Beyer S; Jhawar S; White JR; Bazan JG
    Int J Radiat Oncol Biol Phys; 2023 Oct; 117(2):452-460. PubMed ID: 37059233
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development and Validation of a Normal Tissue Complication Probability Model for Lymphedema After Radiation Therapy in Breast Cancer.
    Park YI; Chang JS; Ko H; Im SH; Kim JS; Byun HK; Kim YB; Jung W; Kim K; Hong CS
    Int J Radiat Oncol Biol Phys; 2023 Aug; 116(5):1218-1225. PubMed ID: 36739918
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Risk factors for regional nodal failure after breast-conserving therapy: regional nodal irradiation reduces rate of axillary failure in patients with four or more positive lymph nodes.
    Grills IS; Kestin LL; Goldstein N; Mitchell C; Martinez A; Ingold J; Vicini FA
    Int J Radiat Oncol Biol Phys; 2003 Jul; 56(3):658-70. PubMed ID: 12788171
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Risk of Lymphedema Following Contemporary Treatment for Breast Cancer: An Analysis of 7617 Consecutive Patients From a Multidisciplinary Perspective.
    Byun HK; Chang JS; Im SH; Kirova YM; Arsene-Henry A; Choi SH; Cho YU; Park HS; Kim JY; Suh CO; Keum KC; Sohn JH; Kim GM; Lee IJ; Kim JW; Kim YB
    Ann Surg; 2021 Jul; 274(1):170-178. PubMed ID: 31348041
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Risk of Subclinical Breast Cancer-Related Lymphedema by the Extent of Axillary Surgery and Regional Node Irradiation: A Randomized Controlled Trial.
    Boyages J; Vicini FA; Shah C; Koelmeyer LA; Nelms JA; Ridner SH
    Int J Radiat Oncol Biol Phys; 2021 Mar; 109(4):987-997. PubMed ID: 33127493
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Radiation Therapy Field Design and Lymphedema Risk After Regional Nodal Irradiation for Breast Cancer.
    Gross JP; Sachdev S; Helenowski IB; Lipps D; Hayes JP; Donnelly ED; Strauss JB
    Int J Radiat Oncol Biol Phys; 2018 Sep; 102(1):71-78. PubMed ID: 30102206
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The influence of axillary surgery and radiotherapeutic strategy on the risk of lymphedema and upper extremity dysfunction in early breast cancer patients.
    Zheng SY; Chen CY; Qi WX; Cai G; Xu C; Cai R; Qian XF; Shen KW; Cao L; Chen JY
    Breast; 2023 Apr; 68():142-148. PubMed ID: 36764019
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Radiation therapy targets and the risk of breast cancer-related lymphedema: a systematic review and network meta-analysis.
    Shaitelman SF; Chiang YJ; Griffin KD; DeSnyder SM; Smith BD; Schaverien MV; Woodward WA; Cormier JN
    Breast Cancer Res Treat; 2017 Apr; 162(2):201-215. PubMed ID: 28012086
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of regional nodal irradiation in the management of patients with early-stage breast cancer treated with breast-conserving therapy.
    Vicini FA; Horwitz EM; Lacerna MD; Brown DM; White J; Dmuchowski CF; Kini VR; Martinez A
    Int J Radiat Oncol Biol Phys; 1997 Dec; 39(5):1069-76. PubMed ID: 9392546
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lymphedema after regional nodal irradiation for breast cancer: a retrospective cohort study.
    Park JS; Kim YS; Kim HY; Choi Y
    Ann Surg Treat Res; 2024 Jun; 106(6):337-343. PubMed ID: 38868589
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Axillary lymph node dissection can be omitted in patients with limited clinically node-positive breast cancer: a National Cancer Database analysis.
    Cocco D; Shah C; Wei W; Wilkerson A; Grobmyer SR; Al-Hilli Z
    Br J Surg; 2022 Nov; 109(12):1293-1299. PubMed ID: 36066266
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Eight-year follow up result of the OTOASOR trial: The Optimal Treatment Of the Axilla - Surgery Or Radiotherapy after positive sentinel lymph node biopsy in early-stage breast cancer: A randomized, single centre, phase III, non-inferiority trial.
    Sávolt Á; Péley G; Polgár C; Udvarhelyi N; Rubovszky G; Kovács E; Győrffy B; Kásler M; Mátrai Z
    Eur J Surg Oncol; 2017 Apr; 43(4):672-679. PubMed ID: 28139362
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Modern Rotational Radiation Techniques with Volumetric Modulated Arc Therapy or Helical Tomotherapy for Optimal Sparing of the Lung and Heart in Left-Breast Cancer Radiotherapy Plus Regional Nodal Irradiation: A Comparative Dosimetric Analysis.
    Hou PY; Hsieh CH; Wu LJ; Hsu CX; Kuo DY; Lu YF; Tien HJ; Hsiao HW; Shueng PW; Hsu SM
    Cancers (Basel); 2021 Oct; 13(20):. PubMed ID: 34680189
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association Between Regional Nodal Irradiation and Breast Cancer Recurrence-Free Interval for Patients With Low-Risk, Node-Positive Breast Cancer.
    Sit D; Lalani N; Chan E; Tran E; Speers C; Gondara L; Chia S; Gelmon K; Lohrisch C; Nichol A
    Int J Radiat Oncol Biol Phys; 2022 Mar; 112(4):861-869. PubMed ID: 34762971
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prediction of breast cancer-related lymphedema risk after postoperative radiotherapy
    Kim JS; Kim JH; Chang JH; Kim DW; Shin KH
    Front Oncol; 2022; 12():1026043. PubMed ID: 36387231
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Loco-regional therapy and the risk of breast cancer-related lymphedema: a systematic review and meta-analysis.
    Lin Y; Xu Y; Wang C; Song Y; Huang X; Zhang X; Cao X; Sun Q
    Breast Cancer; 2021 Nov; 28(6):1261-1272. PubMed ID: 34106427
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Correlation of Bioimpedance Spectroscopy with Risk Factors for the Development of Breast Cancer-Related Lymphedema.
    Vicini F; Shah C; Whitworth P; Walker M; Shi J
    Lymphat Res Biol; 2018 Dec; 16(6):533-537. PubMed ID: 30133336
    [No Abstract]   [Full Text] [Related]  

  • 20. Quality of Regional Nodal Irradiation Plans in Breast Cancer Patients Across a Large Network-Can We Translate Results From Randomized Trials Into the Clinic?
    Ling DC; Moppins BL; Champ CE; Gorantla VC; Beriwal S
    Pract Radiat Oncol; 2021; 11(1):e30-e35. PubMed ID: 32615162
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.